Article
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.
Proceedings of the National Academy of Sciences of the United States of America - 17 Aug 2010
Bhattacharyya Sanjib, Bhattacharya Resham, Curley Steven, McNiven Mark A, Mukherjee Priyabrata
Abstract excerpt
Treatment with monoclonal antibody (mAbs) is a viable therapeutic option in cancer. Recently, these mAbs such as cetuximab, herceptin, etc., have been used as targeting agents to selectively deliver chemotherapeutics to cancerous cells. However, mechanisms of nanoparticles-mAbs interactions with the target cells and its effect on intracellular trafficking and mechanism are currently unknown. In this paper, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
